公开(公告)号：US11471564B2

公开(公告)日：2022-10-18

申请号：US16804823

申请日：2020-02-28

Applicant: FUJIFILM Corporation

Inventor： Kentaro Nakamura ,  Ryo Kogawa

IPC: A61L27/38 ,  A61K35/28 ,  A61L27/18 ,  A61L27/26 ,  A61L27/44 ,  A61L27/56

Abstract: An object of the present invention is to provide an angiogenic agent that can sufficiently exhibit an angiogenic effect due to mesenchymal stem cells in a state where the angiogenic agent does not allow permeation of host cells while being protected from immune rejection, and a method for method for manufacturing the same. According to the present invention, an angiogenic agent including a mesenchymal stem cell (A); and an immunoisolation membrane (B) that encloses the mesenchymal stem cell is provided.

公开(公告)号：US11439960B2

公开(公告)日：2022-09-13

申请号：US16805075

申请日：2020-02-28

Applicant: FUJIFILM Corporation

Inventor： Kentaro Nakamura ,  Ryo Kogawa ,  Yusuke Mochizuki ,  Ryuta Takegami

IPC: B01D71/68 ,  B01D69/02 ,  B01D71/44

Abstract: An object of the present invention is to provide a cell transplant device having an ability to induce angiogenesis around the cell transplant device, and a method for manufacturing the same. According to the present invention, a cell transplant device including a cell structure (A) that includes a plurality of biocompatible polymer blocks and a plurality of cells of at least one type, and in which at least one of the biocompatible polymer blocks is disposed in gaps between the plurality of cells; and an immunoisolation membrane (B) that encloses the cell structure is provided.